Document is current
Any future updates will be listed below
-
Authors
Scheffges, Claire
Devy, Jérôme
Giustiniani, Jérôme
Francois, Stessy
Cartier, Lucille
Merrouche, Yacine
Foussat, Arnaud
Potteaux, Stéphane
Bensussan, Armand
Marie-Cardine, Anne https://orcid.org/0000-0002-6593-2453
-
Funding
Funding for this research was provided by:
Research Technology National Agency
Alderaan Biotechnology
Institut National de la Santé et de la Recherche Médicale
Research Federative Structure (SFR) Cap Santé
Université Paris-Cité
- License Information
-
More Information
Article History
Received: 13 November 2023
Accepted: 12 February 2024
First Online: 15 February 2024
Declarations
:
: All patients provided informed oral consent and signed a non-opposition form. The study was approved by the local ethics committee (Biological Resource Center of Godinot Institute, agreement no 170551/1371F). Blood from healthy donors was provided by the Blood French Establishment (agreement no 18/EFS/032). Animal experimentation was approved by Reims Champagne Ardennes ethics committee (agreement no E-51-454-2).
: A.M-C, J.G and A.B are founding members of Alderaan Biotechnology. AF has ownership interest (including patents) in Alderaan Biotechnology. No conflicts of interest were disclosed by the other authors.
